Clemens Fischer

Clemens Fischer is serial pharmaceutical and supplement entrepreneur who owns the Futrue Group, a Munich-based holding company with a collection of about 20 drug and R&D companies.

Over the last two decades, he has built and sold a series of companies in the over-the-counter drug and supplement space, from sleep aids to irritable bowel syndrome treatments.

Fischer's newest company is Vertanical, the Munich-based pharmaceutical company developing a cannabinoid-based extract to treat chronic pain.

Vertanical is pursuing approval for its drug Ver-01 in the European Union and eventually in the United States with hopes for it to become the first cannabis-based prescription painkiller.

Born in Weilheim, Germany, Fischer became a medical doctor but stopped practicing medicine decades ago to get an MBA from Harvard and become an entrepreneur.